Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

SummaryCytogenetic and molecular investigations of Acute Lymphoblastic Leukaemia (ALL) have identified the existence of distinct clinical subgroups. Molecular monitoring of clonal Immunoglobulin and T cell receptor (IG/TR) gene rearrangements has become an important tool in stratification of therapy of ALL. In order to determine whether certain features of the patient‐specific rearrangements could hold further prognostic clues or provide information on the cell of origin of ALL, a comprehensive analysis of structural and biological features (V gene usage, coding frame and mutational status and complementarity‐determining region ‐III length) of 473 IG/TR rearrangements identified in 229 adults with ALL was carried out. Distinct variable‐gene usage profiles were identified between ALL subgroups, particularly for patients positive for BCR‐ABL1 compared to MLL‐AFF1 positive leukaemias; suggesting that the former is derived from a more mature B progenitor. Interestingly, occurrence of TRGV1‐TRGV8 was prognostic for better event‐free survival (31% at 4 years with vs. 0% at 4 years without, P = 0·05). The heterogeneity in clinical outcome is suggested by the basic molecular processes of antigen receptor gene rearrangements as shown in this work.

Original publication

DOI

10.1111/j.1365-2141.2009.07966.x

Type

Journal article

Journal

British Journal of Haematology

Publisher

Wiley

Publication Date

02/2010

Volume

148

Pages

394 - 401